Opioid Tolerance Treatment Market by Drug (Alpha2-Adrenoceptor Agonists, NMDA Antagonists, and Others), by Opioid Tolerance Type (Innate Tolerance and Acquired Tolerance), by Administration Route (Enteral and Parenteral), and by End-User (Hospitals & ASCs, Rehabilitation Centers, and Others): Global Market Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global opioid tolerance treatment market expected to generate USD 2,290 million by 2025, at a CAGR of 3.6% between 2019 and 2025. The increasing number of orthopedic surgeries is one of the main growth drivers of the global opioid tolerance treatment market.

04-Jul-2019 | Number of pages: 120 | Report Code: ZMR-4315 | Report Format : | Status : Published

Analysis

Opioids are pain-relieving drugs that work with opioid receptors present in the human brain cell. The cell sends signals that change the perception of pain and uplifts the sense of pleasure in the body. Opioids are psychotropic substance derived from the opium poppy or developed in laboratories, such as heroin and morphine. Regular use or high dosage can create respiratory depression. The increasing number of chronic diseases, such as cancer, is one of the primary reasons for opioids overdose. According to the World Health Organization, in 2016, 65,632 people died due to overdose opioids, i.e., 21% more than the previous years. Every year, 0.65% of opioid-dependent individuals die due to opioid overdose, as per the W.H.O’s.

The increasing number of orthopedic surgeries is one of the main growth drivers of the global opioid tolerance treatment market. The growing occurrences of disease related to chronic pain, such as arthritis, cancer, and back pain is also propelling the opioids tolerance treatment market globally. Additionally, the escalating rise in the number of road accidents and trauma cases along with continuously growing cases of medical procedures is also boosting the demand for opioid-based pain management treatments, which, in turn, is fuelling the global opioid tolerance treatment market growth.

Global Opioid Tolerance Treatment Market

The global opioid tolerance treatment market is fragmented based on drug, administration route, opioid tolerance type, and end-user. Based on drug type, the market includes Alpha2-adrenoceptor agonists, NMDA antagonists, and others. The Alpha2-adrenoceptor agonists are further segmented into Clonidine, Tizanidine, and others. The NMDA antagonists segment is further divided into Dextromethorphan, Ketamine, and others. On the basis of opioid tolerance type, the global opioid tolerance treatment market is categorized into acquired tolerance and innate tolerance. By administration route, the market includes enteral and parenteral. By end-user, the global market comprises hospitals and ASCs, rehabilitation centers, and others.

The Asia Pacific region is expected to register a high growth rate in the global opioid tolerance treatment market, in terms of market share, over the estimated timeframe. North America accounted for the largest share of the global opioid tolerance treatment market in 2018, owing to the high prevalence of chronic diseases and pain associated with such diseases along with the increasing aging regional population, as geriatric people are more susceptible to pain and requires a high dose of opioids for pain relief.

Some major players operating in the global opioid tolerance treatment market are Pfizer, GlaxoSmithKline, Boehringer Ingelheim, Teva Pharmaceutical, Mylan, Otsuka Pharmaceutical, Johnson & Johnson, Aurobindo Pharma, Acorda Therapeutics, and Zydus Cadila.


Related Reports

Dexamethasone Market by Formulation type (liquid, Tablet, Solution for injection, Other), by Patient type (Adult, Pediatric, and Geriatric), by Application (Anti-inflammatory and immunosuppressant effects, Respiratory Distress Syndrome, COVID-19, and Others), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5369 | Report Format:

The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Dexamethasone market alo...Read More

Over-the-Counter Drugs Market - By Product (Cough & Flu Products, Analgesics, Cold, Weight Loss Products, Mineral and Vitamin Supplements, Gastrointestinal Products, Ophthalmic Products, Skin Products, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Aug-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5362 | Report Format:

The report covers forecast and analysis for the over-the-counter drugs market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the over-the-counte...Read More

Remdesivir Market by Dosage (2.5mg, 5mg, 100mg, 200mg), by Patient (Adult, Pediatric, and Geriatric), by Application (Ebola, SARS-COV, MERS-COV, COVID-19), and End user (Hospitals, Clinics, Pharmacy & Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5358 | Report Format:

The report covers forecast and analysis for the Remdesivir market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Remdesivir market along wit...Read More

Immunity Booster Market - by Nature (Organic, Conventional), by Source (Plant-based, Animal-based, Other), by Form (Tablets, Capsules, Powder, Liquid), and Sales Channel (Hypermarkets/Supermarkets, Specialty Stores, Pharmacy & Drug Stores, and Online Retail) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Aug-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5357 | Report Format:

The report covers forecast and analysis for the Immunity booster market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Immunity booster mark...Read More

Hydroxychloroquine Market - By Type (USP Standards Grade, Pharmaceutical Standards Grade, EP Standards Grade, and Others), By Application (Rheumatoid Arthritis, Skin Lesions, Systemic Lupus Erythematosus, Chronic Discoid Lupus Erythematosus, and Others), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Apr-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5346 | Report Format:

The global Hydroxychloroquine market value was estimated at 542 (USD Million) in 2019 and is projected to hit 5,000 (USD Million) by 2025 growing at a CAGR of over 33% during the period from 2019 to 2025. The report offers valuation and analysis of the Hydroxychloroquine market on a global as well...Read More

Request Brochure

COVID-19

A Global Pandemic

Request the coronavirus impact analysis across industries and market

Request impact analysis on this market
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.